13天11板 君正集團(601216.SH)股價創歷史新高
格隆匯8月6日丨君正集團(601216.SH)今日再度漲停,走出13天11板,股價報價9.46元,創歷史新高,暫成交86.37億元,最新總市值近800億元。

君正集團近日的暴漲起因於“螞蟻金服”擬上市,雖然公司一再澄清螞蟻金服擬上市事項不會對公司生產經營產生影響,但並不改股價的上漲態勢;目前該股又被冠上“抗疫”概念,股價繼續狂奔。君正集團8月3日發佈最新風險提示公告稱,對大安製藥不控股;公司目前的主營業務依然為氯鹼化工業務,沒有血液製品、生物醫藥業務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.